Apellis Pharmaceuticals, Inc.
CELL-PENETRATING COMPSTATIN ANALOGS AND USES THEREOF
Last updated:
Abstract:
In some aspects, the present invention cell-penetrating compstatin analog and compositions comprising cell-penetrating compstatin analog. In some aspects, the invention further provides methods of using cell-penetrating compstatin analogs treat a complement-mediated disorder, e.g., to inhibit complement-mediated damage to a cell, tissue, or organ, to inhibit production or release of biologically active C3 cleavage products.
Status:
Application
Type:
Utility
Filling date:
18 Dec 2020
Issue date:
1 Jul 2021